Skip Navigation

European Heart Journal 2000 21(9):702-704; doi:10.1053/euhj.1999.2137
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Harrington, R.A.
Right arrow Articles by Simoons, M.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrington, R.A.
Right arrow Articles by Simoons, M.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

What have we learned from the recent large trials in acute coronary syndromes without ST-segment elevation?

R.A. Harringtona and M.L. Simoonsb

a Division of Cardiology, Department of Medicine, Duke University, Medical Center, Durham, North Carolina, U.S.A.
b Thoraxcentrum-Academisch Ziekenhuis, Erasmus University, Rotterdam, The Netherlands

References

  1. DeWood MA, Spores J, Notske R. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897–902[Abstract]
  2. Lancet. 1986;1:397–401[CrossRef][Medline]
  3. Lancet. 1988;2:349–360[Medline]
  4. Lee KL, Woodlief LH, Topol EJ. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation. 1995;91:1659–1668[Abstract/Free Full Text]
  5. Granger CB, Hirsch J, Califf RM. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation. 1996;93:870–878[Abstract/Free Full Text]
  6. Mahaffey KW, Granger CB, Sloan MA. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation. 1998;97:757–764[Abstract/Free Full Text]
  7. Pilote L, Califf RM, Sapp S. Regional variaton across the United States in the management of acute myocardial infarction. N Engl J Med. 1995;333:565–572[Abstract/Free Full Text]
  8. Mark DB, Hlatky MA, Califf RM. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med. 1995;332:1418–1424[Abstract/Free Full Text]
  9. Granger CB, Califf RM. The GUSTO trials. J Interven Cardiol. 1999;12:13–31
  10. Cohen M, Demers C, Gurfinkel EP. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med. 1997;337:447–452[Abstract/Free Full Text]
  11. Antman EM, McCabe CH, Gurfinkel EP. Enoxaparin prevents death and cardiac ischaemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999;100:1593–1601[Abstract/Free Full Text]
  12. Lancet. 1999;354:701–707[CrossRef][Web of Science][Medline]
  13. N Engl J Med. 1996;335:775–782[Abstract/Free Full Text]
  14. Lancet. 1999;353:429–438[CrossRef][Web of Science][Medline]
  15. Circulation. 1998;97:2386–2395[Abstract/Free Full Text]
  16. N Engl J Med. 1998;339:436–443[Abstract/Free Full Text]
  17. N Engl J Med. 1998;338:1498–1505[Abstract/Free Full Text]
  18. N Engl J Med. 1998;338:1488–1497[Abstract/Free Full Text]
  19. Lancet. 1999;354:708–715[CrossRef][Web of Science][Medline]
  20. Boden WE, O'Rourke RA, Crawford MH. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 1998;338:1785–1792[Abstract/Free Full Text]
  21. Harrington RA. Recent clinical trials of antithrombotics in the management of patients with acute coronary syndromes. Curr Cardiol Rep. 1999;1:181–183[Medline]
  22. Savonitto S, Ardissino D, Granger CB. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707–713[Abstract/Free Full Text]
  23. Boersma E, Pieper KS, Steyerberg EW. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Circulation. 2000;:
  24. Mahaffey KW, Harrington RA, Simoons ML. Stroke in patients with acute coronary syndromes: incidence and outcomes in the Platelet glycoprotein IIb/IIIa in Unstable angina. Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. Circulation. 1999;99:2371–2377[Abstract/Free Full Text]
  25. Heeschen C, Hamm CW, Goldmann, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999;354:1757–1762[CrossRef][Web of Science][Medline]
  26. Akkerhuis KM, Deckers JW, Boersma E. Regional variation in an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes without persistent ST-segment elevation: results from PURSUIT. Eur Heart J. 2000;:
  27. Kleiman NS, Lincoff AM, Flaker GC. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. Circulation. 2000;101:751–757[Abstract/Free Full Text]
  28. Topol EJ, Califf RM. Answers to complex questions cannot be derived from ‘simple’ trials. Br Heart J. 1992;68:348–351[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
F.-J. Neumann, A. Kastrati, and G. Schwarzer
New aspects in the treatment of acute coronary syndromes without ST-elevation: ICTUS and ISAR-COOL in perspective
Eur. Heart J. Suppl., February 1, 2007; 9(suppl_A): A4 - A10.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Harrington, R.A.
Right arrow Articles by Simoons, M.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrington, R.A.
Right arrow Articles by Simoons, M.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?